tetano
Editor, Senior Moderator
Clin Infect Dis
. 2020 Dec 14;ciaa1850.
doi: 10.1093/cid/ciaa1850. Online ahead of print.
Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response
Philippe Selhorst[SUP] 1 2 [/SUP], Sabrina Van Ierssel[SUP] 3 [/SUP], Jo Michiels[SUP] 1 [/SUP], Joachim Mari?n[SUP] 4 2 [/SUP], Koen Bartholomeeusen[SUP] 1 [/SUP], Eveline Dirinck[SUP] 5 [/SUP], Sarah Vandamme[SUP] 6 [/SUP], Hilde Jansens[SUP] 7 6 [/SUP], Kevin K Ari?n[SUP] 1 8 [/SUP]
Affiliations
Abstract
Background: It is currently unclear whether SARS-CoV-2 reinfection will remain a rare event, only occurring in individuals who fail to mount an effective immune response, or whether it will occur more frequently when humoral immunity wanes following primary infection.
Methods: A case of reinfection was observed in a Belgian nosocomial outbreak involving 3 patients and 2 health care workers. To distinguish reinfection from persistent infection and detect potential transmission clusters, whole genome sequencing was performed on nasopharyngeal swabs of all individuals including the reinfection case's first episode. IgA, IgM, and IgG and neutralizing antibody responses were quantified in serum of all individuals, and viral infectiousness was measured in the swabs of the reinfection case.
Results: Reinfection was confirmed in a young, immunocompetent health care worker as viral genomes derived from the first and second episode belonged to different SARS-CoV-2 clades. The symptomatic reinfection occurred after an interval of 185 days, despite the development of an effective humoral immune response following symptomatic primary infection. The second episode, however, was milder and characterized by a fast rise in serum IgG and neutralizing antibodies. Although contact tracing and virus culture remained inconclusive, the health care worker formed a transmission cluster with 3 patients and showed evidence of virus replication but not of neutralizing antibodies in her nasopharyngeal swabs.
Conclusion: If this case is representative of most Covid-19 patients, long-lived protective immunity against SARS-CoV-2 after primary infection might not be likely.
Keywords: COVID-19; SARS-CoV-2; coronavirus; humoral immunity; reinfection; whole genome sequencing.
. 2020 Dec 14;ciaa1850.
doi: 10.1093/cid/ciaa1850. Online ahead of print.
Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response
Philippe Selhorst[SUP] 1 2 [/SUP], Sabrina Van Ierssel[SUP] 3 [/SUP], Jo Michiels[SUP] 1 [/SUP], Joachim Mari?n[SUP] 4 2 [/SUP], Koen Bartholomeeusen[SUP] 1 [/SUP], Eveline Dirinck[SUP] 5 [/SUP], Sarah Vandamme[SUP] 6 [/SUP], Hilde Jansens[SUP] 7 6 [/SUP], Kevin K Ari?n[SUP] 1 8 [/SUP]
Affiliations
- PMID: 33315049
- DOI: 10.1093/cid/ciaa1850
Abstract
Background: It is currently unclear whether SARS-CoV-2 reinfection will remain a rare event, only occurring in individuals who fail to mount an effective immune response, or whether it will occur more frequently when humoral immunity wanes following primary infection.
Methods: A case of reinfection was observed in a Belgian nosocomial outbreak involving 3 patients and 2 health care workers. To distinguish reinfection from persistent infection and detect potential transmission clusters, whole genome sequencing was performed on nasopharyngeal swabs of all individuals including the reinfection case's first episode. IgA, IgM, and IgG and neutralizing antibody responses were quantified in serum of all individuals, and viral infectiousness was measured in the swabs of the reinfection case.
Results: Reinfection was confirmed in a young, immunocompetent health care worker as viral genomes derived from the first and second episode belonged to different SARS-CoV-2 clades. The symptomatic reinfection occurred after an interval of 185 days, despite the development of an effective humoral immune response following symptomatic primary infection. The second episode, however, was milder and characterized by a fast rise in serum IgG and neutralizing antibodies. Although contact tracing and virus culture remained inconclusive, the health care worker formed a transmission cluster with 3 patients and showed evidence of virus replication but not of neutralizing antibodies in her nasopharyngeal swabs.
Conclusion: If this case is representative of most Covid-19 patients, long-lived protective immunity against SARS-CoV-2 after primary infection might not be likely.
Keywords: COVID-19; SARS-CoV-2; coronavirus; humoral immunity; reinfection; whole genome sequencing.